CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway - Concepedia

Concepedia

Publication | Closed Access

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway

769

Citations

19

References

2007

Year

Stephanie Ma, Terence K. Lee, BJ Zheng, Kwok Wah Chan, Xin‐Yuan Guan

Tumor BiologyAkt/pkb Survival PathwayOncologyMedicineCancer BiologyCell BiologyTumor SuppressorPreferential ExpressionStem CellsRadiation OncologyCancer ResearchHealth Sciences

References

	Year	Citations

Page 1